Hypertrophic scar cells fail to undergo a form of apoptosis specific to contractile collagen - The role of tissue transglutaminase

Journal of Investigative Dermatology

Volumn 125, Issue 1, 2005, Pages 72-82

  Linge, Claire ^a   Richardson, Janette ^a   Vigor, Charlotte ^a   Clayton, Elisabeth ^a   Hardas, Bushan ^b   Rolfe, Kerstin J ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b Procyon Biopharma Inc   (Canada)

Author keywords

Apoptosis; Cicatrix; Collagen; Transglutaminase II; Wound healing

Indexed keywords

COLLAGEN GEL; COLLAGENASE; DOXORUBICIN; GELATINASE A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PUTRESCINE;

APOPTOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SCAR FORMATION; WOUND HEALING;

EID: 22144472964     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23771.x     Document Type: Article

References (48)

1. Akasaka Y, Fujita K, Ishikawa Y, et al: Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 9:501-506, 2001
2. Akasaka Y, Ishikawa Y, Ono I, et al: Enhanced expression of caspase-3 in hypertrophic scars and keloid: Induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. Lab Invest 80:345-357, 2000
3. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148: 825-838, 2000
4. Bornstein MB: Reconstituted rattail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. Lab Invest 7:134-137, 1958
5. Bowness JM, Folk JE, Timpl R: Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem 262:1022-1024, 1987a
6. Bowness JM, Henteleff H, Dolynchuk KN: Components of increased labelling with putrescine and fucose during healing of skin wounds. Connect Tissue Res 16:57-70, 1987b
7. Bowness JM, Tarr AH, Wong T: Increased transglutaminase activity during skin wound healing in rats. Biochim Biophys Acta 967:234-240, 1988
8. Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP: Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am 63:787-797, 1981
9. Buckley CD, Pilling D, Henriquez NV: RGD peptides induce apoptosis by direct caspase-3 activation [see comments]. Nature 397:534-539, 1999
10. Chodon T, Sugihara T, Igawa HH, Funayama E, Furukawa H: Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol 157:1661-1669, 2000
11. Crowe MJ, Doetschman T, Greenhalgh DG: Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 115:3-11, 2000
12. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66, 1995
13. Dolynchuk KN: Inhibition of tissue transglutaminase and epsilon (gamma-glutamyl) lysine cross-linking in human hypertrophic scar. Wound Repair Regen 4:16-20, 1996
14. Dolynchuk KN, Bendor-Samuel R, Bowness JM: Effect of putrescine on tissue transglutaminase activity in wounds: Decreased breaking strength and increased matrix fucoprotein solubility. Plast Reconstr Surg 93:567-573, 1994
15. Dolynchuk KN, Pettigrew NM: Transglutaminase levels in Dupuytren's disease. J Hand Surg [Am] 16:787-790, 1991
16. Dolynchuk KN, Ziesmann M, Serletti JM: Topical putrescine (Fibrostat) in treatment of hypertrophic scars: Phase II study. Plast Reconstr Surg 97: 117-123, 1996 (discussion 124-115)
17. Fluck J, Querfeld C, Cremer A, Niland S, Krieg T, Sollberg S: Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol 110:153-157, 1998
18. Frisch SM, Ruoslahti E: Integrins and anoikis. Curr Opin Cell Biol 9:701-706, 1997
19. Fukamizu H, Grinnell F: Spatial organization of extracellular matrix and fibroblast activity: Effects of serum, transforming growth factor beta, and fibronectin. Exp Cell Res 190:276-282, 1990
20. Gaudry CA, Verderio E, Jones RA, Smith C, Griffin M: Tissue transglutaminase is an important player at the surface of human endothelial cells: Evidence for its externalization and its colocalization with the beta(1) integrin. Exp Cell Res 252:104-113, 1999
21. Grenard P, Bresson-Hadni S, El Alaoui S, Chevallier M, Vuitton DA, Ricard-Blum S: Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol 35: 367-375, 2001
22. Griffin M, Casadio R, Bergamini CM: Transglutaminases: Nature's biological glues. Biochem J 368:377-396, 2002
23. Grinnell F, Zhu M, Carlson MA, Abrams JM: Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 248:608-619, 1999
24. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS: Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. Faseb J 13:1787-1795, 1999
25. Hirota A, Ebihara T, Kusubata M, et al: Collagen of chronically inflamed skin is over-modified and upregulates secretion of matrix metalloproteinase 2 and matrix-degrading enzymes by endothelial cells and fibroblasts. J Invest Dermatol 121:1317-1325, 2003
26. Kono T, Tanii T, Furukawa M, et al: Cell cycle analysis of human dermal fibroblasts cultured on or in hydrated type I collagen lattices. Arch Dermatol Res 282:258-262, 1990
27. Mian S, el Alaoui S, Lawry J, Gentile V, Davies PJ, Griffin M: The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression. FEBS Lett 370:27-31, 1995
28. Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: Identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 279:23863-23868, 2004
29. Moulin V, Larochelle S, Langlois C, Thibault I, Lopez-Valle CA, Roy M: Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors. J Cell Physiol 198:350-358, 2004
30. Murthy SN, Wilson J, Guy SL, Lorand L: Intramolecular crosslinking of monomeric fibrinogen by tissue transglutaminase. Proc Natl Acad Sci USA 88:10601-10604, 1991
31. Nakagawa S, Pawelek P, Grinnell F: Extracellular matrix organization modulates fibroblast growth and growth factor responsiveness. Exp Cell Res 182: 572-582, 1989a.
32. Nakagawa S, Pawelek P, Grinnell F: Long-term culture of fibroblasts in contracted collagen gels: Effects on cell growth and biosynthetic activity. J Invest Dermatol 93:792-798, 1989b
33. Nakaoka H, Perez DM, Baek KJ, et al: Gh: A GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264: 1593-1596, 1994
34. Nishiyama T, Tsunenaga M, Nakayama Y, Adachi E, Hayashi T: Growth rate of human fibroblasts is repressed by the culture within reconstituted collagen matrix but not by the culture on the matrix. Matrix 9:193-199, 1989
35. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136:1151-1163, 1997
36. Nusgens B, Merrill C, Lapiere C, Bell E: Collagen biosynthesis by cells in a tissue equivalent matrix in vitro. Coll Relat Res 4:351-363, 1984
37. Paye M, Nusgens BV, Lapiere CM: Modulation of cellular biosynthetic activity in the retracting collagen lattice. Eur J Cell Biol 45:44-50, 1987
38. Ricard-Blum S, Bresson-Hadni S, Guerret S, et al: Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology 111:172-182, 1996
39. Ricard-Blum S, Esterre P, Grimaud JA: Collagen cross-linking by pyridinoline occurs in non-reversible skin fibrosis. Cell Mol Biol (Noisy-le-grand) 39: 723-727, 1993
40. Ricard-Blum S, Hartmann DJ, Esterre P: Monitoring of extracellular matrix metabolism and cross-linking in tissue, serum and urine of patients with chromoblastomycosis, a chronic skin fibrosis. Eur J Clin Invest 28:748-754, 1998
41. Schuster N, Krieglstein K: Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307:1-14, 2002
42. Stephens P, Grenard P, Aeschlimann P, et al: Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci 117:3389-3403, 2004
43. Teofoli P, Barduagni S, Ribuffo M, Campanella A, De Pita O, Puddu P: Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci 22:31-37, 1999
44. Unemori EN, Werb Z: Reorganization of polymerized actin: A possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 103:1021-1031, 1986
45. Verderio E, Gaudry C, Gross S, Smith C, Downes S, Griffin M: Regulation of cell surface tissue transglutaminase: Effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem 47:1417-1432, 1999
46. Verderio EA, Telci D, Okoye A, Melino G, Griffin M: A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 278:42604-42614, 2003
47. Wassermann RJ, Polo M, Smith P, Wang X, Ko F, Robson MC: Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res 75:74-80, 1998
48. Weber L, Meigel WN, Spier W: Collagen polymorphism in pathologic human scars. Arch Dermatol Res 261:63-71, 1978